From COVID-19 to the common cold: UBC scientists identify broadly effective, infection-halting compound
Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold.
Dec 14, 2022
Canadian researchers lead development and testing of promising treatment for COVID-19 variants
A new anti-viral drug could improve COVID-19 outcomes and survival rates — and is highly effective against multiple variants — according to a new study led by researchers at the University of British Columbia and Université de Sherbrooke.
May 11, 2021
UBC researchers unveil first molecular images of B.1.1.7 COVID-19 mutation
UBC researchers are the first in the world to publish structural images of the N501Y mutation on the SARS-CoV-2 spike protein—a change believed to be partly responsible for the highly infectious nature and rapid spread of variant B.1.1.7.
May 3, 2021
UBC experts on SARS-CoV-2 variants
Some Canadian cities are strengthening restrictions, or renewing states of emergencies and stay-at-home orders as COVID-19 cases surge again. The growing number of cases appears to be linked to the quickly spreading P.1 and B.1.1.7 variants. UBC experts are available to comment on related topics.
Apr 8, 2021